CBCB-METHOD
LIVE

Serial Number

88404956

Owner

Farmako GmbH

Attorney

Devasena Reddy

Filing Date

Apr 26, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CBCB-METHOD Trademark

Serial Number: 88404956 • Registration: 6285669

CBCB-METHOD is a trademark filed by Farmako GmbH on April 26, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Farmako GmbH (3 trademarks)

Neue Rothofstraße 13-19
Frankfurt am Main 60313 , DE

Entity Type: 99

Synbionik GmbH (8 trademarks)

Weismüllerstraße 50

Entity Type: 27

Trademark Details

Filing Date

April 26, 2019

Registration Date

March 9, 2021

Published for Opposition

December 22, 2020

Goods & Services

Fungicides, herbicides, namely, antibacterial; flour for pharmaceutical purposes; analgesics; local analgesics; antipyretic analgesics; anti-inflammatory pain patches; analgesic creams; analgesics; universal medical pain-relieving creams; Analgesic pharmaceutical effervescent preparations; Pharmaceutical preparations and substances with analgesic properties; Laxatives; Laxative tablets; Antibiotics; Antiseptics; Veterinary medicinal products, namely, veterinary vaccines; Bath salts for medical purposes; Bath additives in the nature of bath salts for medical purposes; tree bark for pharmaceutical purposes for the treatment of gout; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes for the treatment of cancer; biological preparations for veterinary purposes, namely, veterinary vaccines; Dietary foods for medical purposes; protein supplement preparations for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; fats for medical purposes; freeze-dried foodstuffs for medical purposes; homogenised foodstuffs for medical purposes; allergy and diet capsules for medical purposes; allergy and diet capsules for pharmaceutical purposes; chewing gum for medical purposes; mineral waters for medical purposes; mineral water salts for medicinal purposes; wipes soaked with pharmaceutical lotions; mouthwashes for medical purposes; food supplements; Nerve-attenuating pharmaceutical preparations; therapeutic medicated bath preparations; all the aforesaid goods not containing any cannabis, hemp or CBD

chemical preparations for industrial and scientific use; biological preparations for industrial and scientific use, all the aforesaid goods are for use only with non-consumable, non-medicinal, and non-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

pharmaceutical research services of a development and research company in the fields of biotechnology, pharmacy, medicine, diagnostics and chemistry and information technology; production, development of biotechnological, pharmaceutical and diagnostic processes and products; Development of processes for the production of chemical substances; chemical laboratory services; chemical technical consultancy; scientific and technological services and research and related design services in the field of pharmaceuticals; industrial analysis and research services to assure compliance with industry standards; design and development of computer software; development of pharmaceutical test methods; product design and development; development of industrial products; pharmaceutical research and development services; development of industrial engineering processes; scientific research and development; industrial pharmaceutical drug development services, aforesaid services are for use only with non-consumable, non-medicinal, and non-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2020 CNEA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 11, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 11, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 11, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2020 CRFA
ASSIGNED TO LIE
Oct 19, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2020 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 27, 2019 ASGN
ASSIGNED TO EXAMINER
May 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2019 NWOS
NEW APPLICATION ENTERED
Apr 30, 2019 NWAP